A federal court has just delivered a stinging verdict: CVS Caremark must now shoulder nearly $290 million in damages and penalties after being found complicit in a Medicare Part D overbilling scheme.

CVS Health Corporation CVS is gaining investor attention as the stock trends higher ahead of its second-quarter earnings release, scheduled for July 30, 2025. A key catalyst behind the recent uptick ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. CVS must pay the government at least $95 million ...

CVS Health ( ($CVS) ) has provided an update. On December 9, 2025, CVS Health held its 2025 Investor Day, where it updated ...

The acquisition is an all-stock transaction, giving CVS Health a minority stake in Wellvana, according to a March 4 news release. Details of the deal were not disclosed. Nashville, Tenn.-based ...

(Reuters) -CVS Health Corp on Wednesday forecast a 2023 profit below Wall Street estimates and said it hoped to mitigate the hit from a performance rating decline for its most popular Medicare plan by ...

(Reuters) -CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it overcharged Medicare for prescription drugs. Chief Judge Mitchell Goldberg ...

WOONSOCKET, R.I. — CVS Caremark Corp. said today it will pay $1.25 billion to buy Universal American Corp.'s Medicare prescription drug services unit. CVS said it pursued the deal because with the ...

CVS Caremark Corp., the No. 2 U.S. drugstore chain, agreed to buy Universal American’s Medicare prescription drug business for about $1.25 billion to expand in a growing segment of the pharmacy ...

Deborah Shapiro decided a few months ago to switch her prescription drug coverage from her former employer’s plan to Medicare. The Medicare literature made clear that she could save hundreds of ...

CVS Caremark ended last year with the announcement of its acquisition of Universal American's Medicare Part D business for $1.25 billion, making it the largest provider of prescription drug services ...